Welcome to JN-International Medical Corporation [JN], a U.S. based private  biopharmaceutical corporation, has been developing vaccines for infectious disease and neurological disorders.


Scientific Discovery since 1998 

 JN's Exports most since 1999


JN exports vaccines & diagnostics to over 24 countries and are contract manufactured in USA, India, Brazil and Eastern Europe. JN is equipped with cold room facilities in sub-Saharan Africa and South East Asia to handle cold chain.



News Highlights




2011 FDA authorized JN's IND for conducting Conjugated Meningococcal vaccine human trials in Hanford, California



2011 Neurology scientists bag Neurology Research Award from President Obama stimulus Grant



2006-2011 Meningitis vaccine for Disease outbreaks in India & sub-Saharan Africa





Dr.Reddy & Mr. Hankins at Pharmaceutical conference in Amsterdam



Dr. Orten & Dr. Reddy presented at CNS World Summit in San Francisco




The corporation 

JNI Medical Corp - Admin Building

Do you Know? JN is the 3rd BioPharma, developed patented Meningococcal meningitis serogroups A/C/Y/W135 diphtheria toxoid conjugate vaccine (NmVac-4dt)  Inc5000 Fastest Growing Company.



Meningitis outbreaks  

Vaccine: NmVac4-ACYW135 DTNmVac-4dt is among the most complex biotech or biologic products. It’s a combination vaccine that contains four 4 different vaccines in one and can be used with any combination by the geographic prevalence of the disease causing serogroup A, C, Y & W-135


Neurological THERAPIES
Proof of concept of stroke and neurological diseases


Research Biomarkers and Therapeutics to intervene TIA / Stroke, Epilepsy, Alzheimer's.

  • Vaccine saves mice

  • Auto Antibodies NEWS

  • Biomarkers

  • Stroke therapeutic




Filled Commitment



JN & Clinton Global


US President Malaria Initiative & JN International Medical Corporation


© 1998-2012 JN-International, Inc. Oakland, Nebraska 68045, USA . BYLAWS TERMS OF USE LEGAL DISCLAIMER